Actively Recruiting
Study on the Effects of Chronic Pulmonary Aspergillosis on Health and Well-being
Led by Imperial College London · Updated on 2025-03-20
100
Participants Needed
3
Research Sites
34 weeks
Total Duration
AI-Summary
What this Trial Is About
This research aims to develop and validate a new questionnaire specifically designed to measure the health-related quality of life HRQoL in patients who have Chronic Pulmonary Aspergillosis CPA. The goal is to create a tool that can be used in clinical research and trials to better understand how CPA affects patients health status and well-being over time. The study will not involve any experimental treatments or interventions. Instead, it focuses on observing and collecting information from patients diagnosed with CPA over a period of 30 months. Participants will be asked to complete this novel questionnaire, which is tailored to capture the impact of CPA on their daily lives and overall health. Participants will be involved in providing informed consent and completing the disease-specific questionnaire during the study period. Researchers will monitor and analyze the responses to assess how CPA influences patients quality of life. This observational study is sponsored by Imperial College London and will follow participants for up to 30 months to gather meaningful data on their health status and well-being.
CONDITIONS
Brief Title
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
Research Team
D
Dareen Marghlani, MSc
A
Anand Shah, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
